(MedPage Today) — Patients highly sensitized to HLA successfully underwent kidney transplantation after desensitization with the use of dual chimeric antigen receptor (CAR) T-cell therapy.
In a safety run-in cohort of an ongoing phase I trial…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
